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Abstract
The report “Multiple Chronic Conditions: A Strategic Framework,” which was developed by the U.S. Depart-
ment of Health & Human Services (HSS), has identifi ed as one of the key goals for improving health and the 
provision of healthcare for people with multiple chronic conditions “to increase clinical, community and patient-
centered research.” In their linked commentary of this special journal issue, Parekh and Goodman identify and 
consider the potential impact of a number of related research initiatives supported by the National Institutes of 
Health and the Agency for Health Research and Quality, particularly focusing on two very specifi c areas: behav-
ioral medicine and secondary analyses of available datasets. In this paper, I comment on both documents and 
discuss the opportunities offered by the current approaches and highlight related research needs; in particular, 
the need for an improved and expanded conceptual model of healthcare for people with multimorbidity, and the 
need for further exploration of the use of multimorbidity-relevant outcomes as part of usual clinical practice.
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Introduction
The report “Multiple Chronic Conditions: A Strategic 
Framework,” which was developed by the U.S. Depart-
ment of Health & Human Services (HSS), has identifi ed 
as one of the key goals for improving health and the 
provision of healthcare for people with multiple chronic 
conditions (MCCs) “to increase clinical, community and 
patient-centered research” [1]. In a linked commentary 
in this special issue, Parekh and Goodman have consid-
ered the potential impact of a number of related research 
initiatives supported by the National Institutes of Health 
(NIH) and the Agency for Health Research and Quality 
(AHRQ), particularly focusing on two very specifi c 
areas: behavioral medicine and secondary analyses of 
available datasets [2]. In this paper, I comment on both 
documents and discuss the opportunities offered by the 
current approaches and highlight related research needs.
The report
The U.S. Department of Health & Human Services 
(HHS) report “Multiple Chronic Conditions: A Stra-
tegic Framework,” identifi es research as one of the 
four key goals for improving health and healthcare for 
people with multimorbidity. In particular, the report 
provides recommendations for facilitating “research 
to fi ll knowledge gaps about, and interventions and 
systems to benefi t individuals with multiple chronic 
conditions.” Other goals are related to changes in the 
organization and delivery of healthcare, maximizing 
benefi t from available systems (with a particular focus on 
self-management) and furnishing health and social care 
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professionals working with patients with MCCs with 
specifi c resources [1]. The most ambitious objective 
associated with this research goal is “to increase clini-
cal, community and patient-centered research.” This 
becomes clear when considering the narrower focus of 
the other three objectives: (1) increasing the validity of 
randomized controlled trials, (2) understanding the epi-
demiology of MCCs, and (3) addressing disparities [1].
The report acknowledges that there is insuffi cient 
evidence for both the impact of MCCs on health sta-
tus and the treatment of MCCs. Indeed, a recent 
systematic review and meta-analysis of interventions 
for people with multimorbidity identifi ed ten studies 
involving multifaceted complex interventions [3]. The 
results were mixed and non-conclusive, but suggested 
that interventions focusing on particular risk factors or 
functional diffi culties are likely to be the most effec-
tive. The HHS report makes an explicit call for research 
on prevention, management, and treatment of MCCs. 
To address this, the report calls for an increased focus 
on research activity, on clinical-, self-care-, and com-
munity-based approaches for health promotion, disease 
prevention, and healthcare management of individuals 
with MCCs, as well as on the systems to best support and 
sustain this programing. The existence of current disin-
centives for providers to adequately address the needs of 
individuals with MCCs is also recognized in the report, 
and so is the need for identifying which outcomes are of 
highest importance to individuals with MCCs in order 
to enable clinicians to orient care towards them, calling 
for the development of innovative and reliable methods 
for researchers to improve measurement of patient-cen-
tered outcomes of treatments and other interventions for 
individuals with MCCs. Finally, a third relevant area is 
identifi ed, namely the characterization of patient trajec-
tories in relation to changes in health status, functional 
status, and health services research.
Although there is no attempt in the report to clarify 
the issue, the call for research on clinical, community, 
and patient-centered aspects of health and healthcare for 
patients with MCCs does not identify distinct areas of 
work, but rather overlapping approaches to the relevant 
aspects. In fact, patient centeredness is usually defi ned as 
the provision of care “that is respectful of and responsive 
to individual patient preferences, needs, and values, and 
ensuring that patient values guide all clinical decisions” 
(Institute of Medicine); community care is about the 
provision of clinical care in the community, with the 
aim of having an impact on the closest environments of 
each patient, and the defi nition of the ‘patient-centered 
medical home’ makes explicit references to the inclusion 
of community services and interventions [4], to consider 
but a few instances that demonstrate the deep interrela-
tionship between these approaches.
Research initiatives
In their linked commentary, Parekh and Goodman iden-
tify a number of related research initiatives supported by 
the NIH and the AHRQ [2]. Specifi cally, they identify 
four funding opportunities announced by the NIH in 
the period 2010–2013 aimed at fostering extramural 
research in two very specifi c areas: behavioral medicine 
and secondary analyses of available datasets. Behavioral 
approaches are related both to behavioral treatments and 
more generally to research methods and measures for 
conceptualizing, triaging, and assessing health behaviors 
(e.g. concordance and adherence to treatment, mental 
health problems, diet and exercise, and substance use/
abuse disorders) and behavioral interventions. Second-
ary data analyses focus mostly on specifi c combinations 
of MCCs or medications for assessing costs, differences 
in effectiveness and safety of different treatment regi-
mens, risks for specifi c benefi cial and/or adverse health 
outcomes, interactions among medications, disease 
processes, and health outcomes, and generally meth-
odological issues relevant to the analyses of the health 
impact or treatment of MCCs. The AHRQ, on the other 
hand, has led to the creation of the “MCC Research Net-
work,” with a focus on comparative effectiveness, quality 
improvement, and patient-centered outcomes research. 
Both institutions and the Patient-Centered Outcomes 
Research Institute convened a meeting focusing on the 
health of people with MCCs in which contextual fac-
tors and relevant research methods were explored, and a 
research agenda was developed.
Parekh and Goodman conclude that the Strategic 
Framework provides a useful roadmap to foster coordi-
nation between HHS operating divisions and enhance 
collaboration with external stakeholders in MCC 
research [2]. They consider that HHS agencies and pro-
grams have productively used the framework to guide 
new research initiatives which, among others, have sup-
ported studies to improve the quality and effectiveness 
of medical management of persons with MCCs, while 
at the same time highlighting additional priority areas, 
notably the characterization of research opportunities of 
huge potential (such as interventions aimed at patients 
with combinations of prevalent high-impact concordant 
conditions), the availability of local level data, or the tai-
loring of data for specifi c use, such as the development of 
comorbidity-sensitive clinical practice guidelines.
My colleagues and I agree with Parekh and Good-
man that a common framework is of utmost importance 
for moving this fi eld decisively forward [5]. The frame-
work stops short of presenting a conceptual model that 
could guide the effort. This is also evidenced, as men-
tioned before, by the lack of clarity as to whether the 
call for research refers to distinct areas or (more likely) 
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to overlapping approaches. A conceptual model has been 
developed as a result of the associated efforts [6], but it 
would be key for ensuring progress that this conceptual 
model is expanded in its scope, ambition, and relevance 
for healthcare systems worldwide (the current model has 
been specifi cally developed for developing and applying 
classifi cation schemes for chronic conditions to data ele-
ments for studying and monitoring health conditions in 
the USA). The framework proposed in the report should 
also be reworked in light of the improved conceptual 
model. This would ensure a more consistent and struc-
tured approach to the identifi cation of the research needs 
in this area.
Outcome priorities
Perhaps one of the more interesting issues in the report 
is the recognition of the need for identifying which out-
comes are of highest importance to individuals with 
MCCs. Although a body of qualitative work is build-
ing up aiming precisely at identifying the problems that 
people with MCCs face (which is starting to be sum-
marized [7]), the issue of what the outcomes of interest 
are has not yet been suffi ciently explored. This issue is 
not at all trivial. Patients may be potentially interested 
in process-oriented intermediate outcomes, such as 
increasing their ability to manage and cope with their 
conditions and their potentially competing demands, 
as well as their proper health outcomes such as symp-
toms, functioning, perceived health or health-related 
quality of life [8]. At the same time, the question seems 
to imply that there are more-or-less standard outcomes 
that can be used for evaluating the results for all patients 
with MCCs. The likely realization that outcomes may 
vary from patient to patient and the huge diversity of 
problems posed by different combinations of condi-
tions and different individual preferences for outcomes 
has the potential for suggesting that a reorientation of 
the question is required. There is therefore the poten-
tial for processes to be developed that will in themselves 
allow the tailoring of outcomes for the desired processes 
of care [9]. Such processes will most likely need to be 
centered around the fi gure of the physician responsible 
for providing the bulk of care and/or for coordinating 
healthcare across the different conditions – a role most 
frequently played in the various systems by primary care 
physicians (general practitioners and family physicians in 
most countries, along with internists and pediatricians 
in the USA).
The promising potential for behavioral approaches to 
improve healthcare and outcomes in people with MCCs 
is recognized. Smoking and obesity have a shared eti-
ological role in many conditions that may develop in 
the same individual, and they are particularly sensitive 
to such approaches along with broader public health 
interventions.
Parekh and Goodman very appropriately identify 
secondary data analyses as a priority. The amount of 
information on the epidemiology and health services 
and broader social implications of the simultaneous 
presence of MCCs that have already been collected as 
part of research studies, routine health surveys, and rou-
tinely collected data is huge. Proper analysis of these vast 
resources is a most effi cient approach to advancing our 
knowledge in this area and any researcher with an inter-
est in MCCs should seriously consider focusing on them 
as a fi rst step [10,11]. Funding sources should also stimu-
late this type of research, recognizing their prominent 
role, not least also for their potential for the generation 
of hypothesis in relation to best models of management.
Conclusion
The initiatives described in the linked commentary 
demonstrate the commitment of the research com-
munity towards improving the evidence base for the 
management of people with MCCs. Although there 
has been progress on a number of issues, the astonish-
ing truth is that still know very little is known about 
best practice for these patients, although they represent 
the group with highest impact on the health service 
and also one with worst outcomes. Priority areas in 
this respect would be the development of an improved 
and expanded conceptual model for the delivery of 
healthcare to people with multimorbidity, and the char-
acterization of multimorbidity-relevant outcomes that 
could be used in clinical practice. Advancing this area of 
research is obviously a priority both in terms of costs and 
health impact, and will pave the ground for new models 
of care that truly link the most advanced and techno-
logically sophisticated medical care with approaches to 
the delivery of healthcare that are person-centred and 
individually sensitive.
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